US Go-Ahead for Percutaneous Transluminal Coronary Angioplasty Balloon Dilation Catheters

Published date : 01 October 2012
Article date : 01 October 2012

Massdevice reports that Boston Scientific has won FDA clearance for the Emerge percutaneous transluminal coronary angioplasty balloon dilation catheters in treatment of coronary artery disease, he leading cause of death in the US. They say that the devices, used during angioplasty and stenting procedures, help open clogged arteries that, left untreated, could lead to heart attack.
The company has already begun marketing the device, offering both Monorail and Over-The-Wire balloon catheter options, according to a company press release. 
Earlier this year, the Natick won CE Mark approval in the EU for the Emerge PTCA line and began commercialisation, immediately. Apparently, the catheters are also available in a range of sizes from 1.2mm up to 4mm, with balloon lengths ranging from 8mm up to 30mm. 
Source: Massdevice, 27 September 2012.
Read the full article here.
Back to Listings

WhichMedicalDevice is a FREE resource created by clinicians for clinicians.

Registration is free and gives you unlimited access to all of the content and features of this website.

Find out more...

Please sign in to view this content...

I have forgotten my password
Not a Member?

Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...

Why Register

Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.

We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.